Quarterly report pursuant to Section 13 or 15(d)

Revision to Prior Period Financial Statements

v3.21.1
Revision to Prior Period Financial Statements
3 Months Ended
Mar. 31, 2021
Revision to Prior Period Financial Statements  
Revision to Prior Period Financial Statements

Note 9 — Revision to Prior Period Financial Statements

During the course of preparing the quarterly report on Form 10-Q for the three months ended March 31, 2021, the Company identified a misstatement in its misapplication of accounting guidance related to the Company’s Warrants in the Company’s previously issued audited balance sheet dated February 2, 2021, filed on Form 8-K on February 8, 2021 (the “Post-IPO Balance Sheet”).

On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the Warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since their issuance on February 2, 2021, the Company’s Warrants have been accounted for as equity within the Company’s previously reported balance sheet. After discussion and evaluation, including with the Company’s audit committee, management concluded that the warrants should be presented as liabilities with subsequent fair value remeasurement.

The Warrants were reflected as a component of equity in the Post-IPO Balance Sheet as opposed to liabilities on the balance sheet, based on the Company’s application of ASC 815-40. The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued on February 2, 2021, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company’s statement of operations each reporting period.

The Company concluded that the misstatement was not material to the Post-IPO Balance Sheet and the misstatement had no material impact to any prior interim period. The effect of the revisions to the Post-IPO Balance Sheet is as follows:

    

As of February 2, 2021

As Previously

Revised

  

    

Reported

    

Adjustment

    

As Revised

Balance Sheet

 

  

 

  

 

  

Total assets

$

289,785,365

$

$

289,785,365

Liabilities, redeemable non-controlling interest and shareholders’ equity

 

  

 

  

 

  

Total current liabilities

$

642,351

$

$

642,351

Deferred underwriting commissions

 

10,062,500

 

 

10,062,500

Derivative warrant liabilities

 

 

10,638,000

 

10,638,000

Total liabilities

 

10,704,851

 

10,638,000

 

21,342,851

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

 

274,080,510

 

(10,638,000)

 

263,442,510

Shareholders’ equity

 

  

 

  

 

  

Preference shares - $0.0001 par value

 

 

 

Class A ordinary shares - $0.0001 par value

 

214

 

107

 

321

Class B ordinary shares - $0.0001 par value

 

719

 

 

719

Additional paid-in-capital

 

5,030,402

 

590,767

 

5,621,169

Accumulated deficit

 

(31,331)

 

(590,874)

 

(622,205)

Total shareholders’ equity

 

5,000,004

 

 

5,000,004

Total liabilities and shareholders’ equity

$

289,785,365

$

$

289,785,365